🔗 Share this article

Treasury head Reeves has announced she is preparing "focused steps to address household expense issues" in the forthcoming financial statement.

In comments to the BBC, she emphasized that lowering price rises is a joint responsibility of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the most elevated among the G7 advanced economies this calendar year and next.

Potential Energy Bill Measures

Sources suggest the administration could take action to lower utility costs, for instance by reducing the current 5% rate of VAT charged on energy supplies.

A further approach is to cut some of the regulatory levies presently added to bills.

Fiscal Constraints and Expert Predictions

The administration will receive the next report from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for these measures.

The consensus from most economists is that the Chancellor will have to announce higher taxes or expenditure reductions in order to fulfill her declared debt limits.

Earlier on the same day, estimates showed there was a £22bn deficit for the Treasury chief to resolve, which is at the lower end of expectations.

"It is a joint job between the Bank of England and the government to continue tackling some of the sources of price increases," the Chancellor stated to the BBC in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Pledges and Global Concerns

While much of the attention has been on likely tax increases, the chancellor said the most recent figures from the OBR had not altered her pledge to manifesto promises not to increase tax levels on income tax, sales tax or social security contributions.

She blamed an "uncertain world" with rising geopolitical and commercial tensions for the fiscal revenue measures, likely to be focused on those "wealthiest."

Global Trade Tensions

Commenting on worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests always come first."

Last week's statement by Chinese authorities to increase export controls on rare earths and other resources that are key for advanced tech manufacturing led American leader Donald Trump to propose an further 100% tariff on goods from China, raising the risk of an all-out commercial conflict between the two global powers.

The US Treasury Secretary described the Chinese decision "economic coercion" and "a international production control attempt."

Asked about considering the US offer to participate in its battle with the Asian nation, Reeves said she was "extremely troubled" by China's measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the move was "harmful for the world economy and generates additional challenges."

"I believe there are sectors where we need to confront Chinese policies, but there are also significant chances to export to China's economy, including banking sector and other areas of the economic system. We've got to achieve that balance right."

The Treasury chief also stated she was working with international partners "regarding our own critical minerals strategy, so that we are reduced dependence."

NHS Drug Costs and Investment

The Chancellor also admitted that the cost the National Health Service spends on pharmaceuticals could go up as a result of ongoing discussions with the US government and its drugs companies, in exchange for reduced taxes and capital.

Some of the biggest global drug companies have said recently that they are either halting or canceling investments in the UK, with several attributing the low prices they are obtaining.

Recently, the Science Minister said the price the NHS spends on medicines would must go up to stop businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor told media: "We have seen as a result of the payment system, that clinical trials, recent pharmaceuticals have not been provided in the United Kingdom in the way that they are in other European countries."

"The objective is to ensure that individuals receiving treatment from the National Health Service are can obtain the best critical drugs in the world. And so we are reviewing this situation, and... looking to secure increased capital into Britain."